[1]
S. R. Balaguragi, A. Sen, P. M. Mathew, and V. Suresh, “Nilotinib In Parkinson’s Disease: A Therapeutic Pathway Yet to Be Fulfilled ”, JR, vol. 3, no. 2, pp. 49–53, May 2025.